177 related articles for article (PubMed ID: 198304)
21. [Subtypes of the foot-and-mouth disease virus type O. Their antigenic and immunologic properties and mutual relationships].
Wittmann G
Zentralbl Bakteriol Orig; 1964 Sep; 194(1):1-25. PubMed ID: 4284199
[No Abstract] [Full Text] [Related]
22. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
Tekerlekov P; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
[No Abstract] [Full Text] [Related]
23. [Role of antibodies in the antigenic variability of the foot-and-mouth disease virus].
Salazhov EL; Avilov VS; Rebenkov AG
Veterinariia; 1976; (9):31-2. PubMed ID: 186935
[No Abstract] [Full Text] [Related]
24. Virus content and effectiveness of foot-and-mouth disease vaccines.
Czelleng F; Sólyom F
Acta Microbiol Acad Sci Hung; 1976; 23(1):77-81. PubMed ID: 180758
[TBL] [Abstract][Full Text] [Related]
25. Immunology of foot-and-mouth disease in swine: experimental inactivated-virus vaccines.
Bachrach HL; McKercher PD
J Am Vet Med Assoc; 1972 Feb; 160(4):521-6. PubMed ID: 4337840
[No Abstract] [Full Text] [Related]
26. A simple quantitative microtest for determination of the complement fixing activity of foot-and-mouth disease virus.
Petr G; Láznicka F
Acta Virol; 1972 Mar; 16(2):133-40. PubMed ID: 4401070
[No Abstract] [Full Text] [Related]
27. [Production of purified foot-and-mouth disease virus antigens and the specific sera against them].
Tekerlekov P; Nikolova E; Vasileva L
Vet Med Nauki; 1978; 15(6):21-8. PubMed ID: 85363
[TBL] [Abstract][Full Text] [Related]
28. [Safety of foot-and-mouth disease vaccines in cell cultures].
Tekerlekov P; Dilovski M; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(1):21-5. PubMed ID: 6287707
[TBL] [Abstract][Full Text] [Related]
29. The detection of foot-and mouth disease virus antigens in infected cell cultures by immuno-peroxidase techniques.
Sutmoller P; Cowan KM
J Gen Virol; 1974 Feb; 22(2):287-91. PubMed ID: 4362406
[No Abstract] [Full Text] [Related]
30. [Antigenic structures of the foot-and-mouth disease virus].
Marchev N; Veleva E; Tsutsumanski V
Vet Med Nauki; 1976; 13(9):100-4. PubMed ID: 67699
[No Abstract] [Full Text] [Related]
31. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
[TBL] [Abstract][Full Text] [Related]
32. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
Warrington RE; Cunliffe HR; Bachrach HL
Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
[No Abstract] [Full Text] [Related]
33. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
Bauer K
Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
[No Abstract] [Full Text] [Related]
34. Antibody response of tropical range cattle to foot-and-mouth disease virus. II. Evaluation of response to O-1, A-27, and A-18 subtypes.
Arias CA; Hanson RP; de Gerardino AG
Dev Biol Stand; 1976; 35():215-20. PubMed ID: 198289
[No Abstract] [Full Text] [Related]
35. Investigations on the suitability of mice for potency testing of FMD vaccines.
Bernhardt D; Runge W; Restle H
Dev Biol Stand; 1976; 35():285-8. PubMed ID: 198296
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains].
Eissner G; Böhm HO
Dev Biol Stand; 1976; 35():279-83. PubMed ID: 198295
[No Abstract] [Full Text] [Related]
37. [The antigenic and immunologic properties and relations of A subtypes of the foot-and-mouth disease virus. II. After vaccination of guinea pigs with formalin-adsorbate].
Wittmann G
Zentralbl Veterinarmed B; 1966 Aug; 13(4):321-33. PubMed ID: 4292121
[No Abstract] [Full Text] [Related]
38. [Antigenic and immunological relationships between the A sub-types of the foot-and-mouth disease virus. 1. After inoculation of guinea-pigs with active virus].
Wittmann G
Zentralbl Veterinarmed B; 1966 Jun; 13(3):225-38. PubMed ID: 4290978
[No Abstract] [Full Text] [Related]
39. [The role of foot-and-mouth disease antibodies of sera in BHK 21 industrial cell cultures used for the production of vaccines].
Mammerickx M; Leunen J
Bull Off Int Epizoot; 1968; 69(3):487-96. PubMed ID: 4303694
[No Abstract] [Full Text] [Related]
40. [Antigenic properties of strains of A 22 foot-and-mouth disease virus isolated in epizootic conditions].
Salajov EL; Antoniouk VP
Bull Off Int Epizoot; 1972; 77(5):929-34. PubMed ID: 4350008
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
